Literature DB >> 16205026

Valvular and supravalvular aortic stenosis in heterozygous familial hypercholesterolemia, a case report.

Kiyoshi Ozumi1, Hiromi Tasaki, Kazuhiko Yamashita, Seiya Tanaka, Takakazu Sasaguri, Yasuyuki Sasaguri, Yasuhide Nakashima.   

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by a high level of LDL-cholesterol and frequent coronary atherosclerosis. We studied a 64 year old woman with heterozygous (hetero) FH, who showed symptoms of chest pain and dyspnea with no other coronary risk factors than post-menopause and hypercholesterolemia. Although her coronary symptoms didn't reveal significant stenosis on coronary angiography, she had severe aortic valvular and supravalvular stenosis at the ascending aorta, which qualified her for aortic valve replacement. Moreover, a coronary flow study revealed functional ischemia with a reduction of the coronary flow reserve. We report a case of valvular and supravalvular aortic stenosis corrected by aortic valve replacement, a rare complication of hetero FH.

Entities:  

Mesh:

Year:  2005        PMID: 16205026     DOI: 10.5551/jat.12.289

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  3 in total

1.  A rare case of hypercholesterolemia in a young girl.

Authors:  Prabhat Kumar; Amit Devgan; Gaurav Kumar; Hasnain Shahbaz
Journal:  Med J Armed Forces India       Date:  2012-12-29

Review 2.  Familial hypercholesterolemia--epidemiology, diagnosis, and screening.

Authors:  Siddharth Singh; Vera Bittner
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

3.  A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia.

Authors:  Xiaoyue Ge; Tiantian Zhu; Hao Zeng; Xin Yu; Juan Li; Shanshan Xie; Jinjin Wan; Huiyao Yang; Keke Huang; Weifang Zhang
Journal:  Biomed Res Int       Date:  2021-10-31       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.